This is custom heading element

For the advancement of diabetes research

In the spotlight

FFRD updates and presentation of the 2024 awardees to the press!

 

As every year begins, the FFRD is delighted to showcase its awardees and their projects while reflecting on the key moments of 2024:

 

  • €8.3 million distributed since 2013

  • 31 Francophones awardees recognized
  • The FFRD supports all diabetes research fields: clinical, translational and fundamental
  • Focus on research advances and type 1 diabetes
  • 1st FFRD symposium on the B cell, at the 2024 SFD congress in Toulouse
  • The SFDT1 study, led by the FFRD, continues to grow!
  • Discussions with researchers and key players in Francophone diabetes research

 

Exciting news for 2025 from the FFRD…

New governance, a new call for projects and new timeline, a new FFRD symposium on the gut microbiota at the SFD congress in Paris and new partnerships on the horizon!

 

DISCOVER OUR PRESS RELEASE!

News

The upcoming events of the FFRD

18
Feb
Board webconference

Definition of the New 2025 Strategy
Development of the Specifications Document
Implementation of actions

19
Mar
ATTD Congress from 19 to 22 March - Amsterdam

Advanced Technology & Treatments for Diabetes
Developping the reputation of the FFRD
Strengthen its
existing partnerships
Find new partners and donors

Photo BV_Light

President’s foreword

The Francophone Foundation for Diabetes Research (FFRD) serves as the “armed wing” of the Francophone Diabetes Society (SFD) with the aim of promoting excellence in diabetes research, a common disease whose prevalence continues to rise. High-level and large-scale research is truly essential to get further insight into the mechanisms involved in the development of diabetes and its complications, as well as to improve their treatment and prevention.

The FFRD supports all research on diabetes.

The FFRD supports clinical, basic, and translational research.

The supported basic research projects address major themes of type 1 and type 2 diabetes

covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.

The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes

and often involve large multicenter cohort studies.

Since 2013, the Foundation has been:

0
years of existence
0
teams of supported researchers
0
euros in annual grants
0
million of euros distributed
0
% of expenses allocated to research

The recipients of the year

Pierre GOURDY
Pierre GOURDY
Cardiovascular and Metabolic diseases Institute, Inserm, CHU in Toulouse
Translational Research Project
300 000
Alfonso GALDERISI
Alfonso GALDERISI
Robert Debré, Hospital, University Paris Cité
Clinical Research Project
300 000

They support us